Eli Lilly pauses trial of its monoclonal antibody to treat Covid-19 for safety reasons

Drugmaker Eli Lilly says it is pausing its trial of a combination antibody treatment for coronavirus due to safety reasons

From CNN's Dan KamalThe Philadelphia Eagles announced they will welcome fans to Lincoln Financial Field for the first time this season for their game vs. the Baltimore Ravens on Sunday.

In making the announcement Tuesday, Eagles president Don Smolenski said, “We have been working very closely with state and local officials, public health experts and the National Football League on a number of scenarios to safely bring Eagles fans back to Lincoln Financial Field. After many thoughtful and active discussions, we are thrilled to announce that the fan experience will return to Lincoln Financial Field this Sunday.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

CNN /  🏆 4. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

J&J Vaccine Pause Shows Challenges Still Ahead for Covid-19 ShotsThe suspension of Johnson & Johnson’s trials poses another setback for global efforts to develop a shot to protect lives and jump-start economies battered by the pandemic, as well as a reminder of the challenges of fast-tracking vaccine development.
Read more »

Johnson & Johnson pauses Covid-19 vaccine trial after 'unexplained illness'Johnson&Johnson said its Janssen arm had paused its coronavirus vaccine trial after an 'unexplained illness' in one of the volunteers testing its experimental Covid-19 shot.
Read more »

2nd COVID-19 vaccine trial paused over unexplained illnessBREAKING: Johnson & Johnson pauses its COVID-19 vaccine trial while the company investigates a participant’s “unexplained illness.” The company said such illnesses, accidents and similar adverse events are an expected part of large clinical studies.
Read more »

Second COVID-19 vaccine trial paused over unexplained illnessA late-stage study of Johnson & Johnson’s COVID-19 vaccine candidate has been paused while the company investigates whether a study participant’s “unexplained illness” is related to the shot.
Read more »

2nd COVID-19 vaccine trial paused over unexplained illnessA late-stage study of Johnson & Johnson’s COVID-19 vaccine candidate has been paused while the company investigates whether a study participant’s “unexplained illness” is related to the shot
Read more »